SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-04-028434
Filing Date
2004-09-10
Accepted
2004-09-10 11:30:23
Documents
8
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 10-K a2143233z10-k.htm 10-K 515330
2 EXHIBIT 10.7 a2143233zex-10_7.htm EX-10.7 17555
3 EXHIBIT 10.8 a2143233zex-10_8.htm EX-10.8 34784
4 EXHIBIT 21.1 a2143233zex-21_1.htm EX-21.1 2133
5 EXHIBIT 23.1 a2143233zex-23_1.htm EX-23.1 2401
6 EXHIBIT 31.1 a2143233zex-31_1.htm EX-31.1 6116
7 EXHIBIT 31.2 a2143233zex-31_2.htm EX-31.2 6120
8 EXHIBIT 32 a2143233zex-32.htm EX-32 3962
  Complete submission text file 0001047469-04-028434.txt   590713
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-26642 | Film No.: 041024293
SIC: 2835 In Vitro & In Vivo Diagnostic Substances